NEJM
New England Journal of Medicine
NEJM
Clinician
NEJM
Evidence
NEJM
AI
NEJM
Catalyst
NEJM
Voices
Loading...
Clinical Conversations
Video: Anticoagulation in Intermediate-Risk AFib
Oct 21
1:40
October 21
1:40
October 21
1:40
Related Content
Original Article
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
Editorial
Anticoagulation for Atrial Fibrillation with a Single Risk Factor for Stroke
Topics
Cardiology
Anticoagulation/Thromboembolism (Cardiology)
Arrhythmias/Pacemakers/Defibrillators
Clinical Medicine
Ambulatory Medicine
A healthy 51-year-old has AFib and a CHA
2
DS
2
-VASc of 1. Should you start him on a DOAC?
Watch the video below.
Read the
New England Journal of Medicine
paper
and
editorial
.
Anticoagulation in Intermediate-Risk AFib
1:40
Featuring
Rahul B. Ganatra, M.D., M.P.H.
Disclosures
Editorial Boards
The Curbsiders
Grant Recipient/Research Support
Veterans Health Administration
Rahul B. Ganatra, M.D., M.P.H.
Disclosures
Editorial Boards
The Curbsiders
Grant Recipient/Research Support
Veterans Health Administration